Sangon Biotech: difference between revisions
Diff·revision 32 → 33·13:29, 19 Jun 2025
Difference between revision 32 and revision 33 of Sangon Biotech. 6 lines changed; the page grew by 467 bytes.
| Revision 32 — 02:22, 11 Jun 2025 CategoryBot (talk) bot: normalise citation format 7,395 bytes ±0 | Revision 33 — 13:29, 19 Jun 2025 EndotoxinEd (talk) correct molar mass 7,862 bytes +467 | ||
|---|---|---|---|
| 17 | | Documentation = Batch certificate of analysis reported with orders | 17 | | Documentation = Batch certificate of analysis reported with orders |
| 18 | | Independent reports = Submitted to this wiki by purchasers; see §Independent testing record | 18 | | Independent reports = Submitted to this wiki by purchasers; see §Independent testing record |
| + | 19 | <!-- PeptidePedia reception tally --> | |
| + | 20 | | Submissions = 751 to July 2026 | |
| + | 21 | | Evidence quality = '''Weak''' — self-selected, self-reported | |
| 19 | }} | 22 | }} |
| 20 | {{hatnote|This article is about the organisation. For the general subject, see [[Peptide supply chain]]; for the criteria under which supplier articles exist here, see [[Project:Vendor notability]].}} | 23 | {{hatnote|This article is about the organisation. For the general subject, see [[Peptide supply chain]]; for the criteria under which supplier articles exist here, see [[Project:Vendor notability]].}} |
| ⋮ | ⋮ | ||
| 54 | 57 | ||
| 55 | Because the reagent business operates in a market with its own documentation conventions, purchasers have occasionally compared the two and found the reagent-line paperwork more standardised than the peptide-line paperwork.{{r|reports}} That comparison is within one organisation and is therefore more informative than a comparison across organisations, but it rests on a small number of reports. | 58 | Because the reagent business operates in a market with its own documentation conventions, purchasers have occasionally compared the two and found the reagent-line paperwork more standardised than the peptide-line paperwork.{{r|reports}} That comparison is within one organisation and is therefore more informative than a comparison across organisations, but it rests on a small number of reports. |
| + | 59 | ||
| + | 60 | == Reception == | |
| + | 61 | The PeptidePedia tally records 751 self-reported submissions to July 2026. Recurring positive themes are catalogue breadth and documentation on the reagent lines; recurring complaints concern inconsistency between the two documentary traditions.{{r|tally}} Self-selected; reception rather than quality.{{r|tally}} | |
| 56 | 62 | ||
| 57 | == References == | 63 | == References == |